Endoscopy News and Research

RSS

CellSeed, LA BioMed enter two-year research agreement to study core technology in regenerative medicine

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and CellSeed Inc., a Japanese biotechnology firm, have entered into a two-year research agreement to study CellSeed's proprietary core technology in regenerative medicine, "Cell Sheet Engineering," LA BioMed President and CEO David I. Meyer, PhD, announced today.

28 Feb 2011

USPI fourth quarter consolidated net revenues increase 3.5% to $154.2 million

United Surgical Partners International, Inc. today announced results for the fourth quarter and year ended December 31, 2010.

28 Feb 2011

MRG projects growth standouts in European surgical procedures for next five years

According to Millennium Research Group, the global authority on medical technology market intelligence, growth standouts in European surgical procedures over the next five years will be in percutaneous heart valve procedures, arthroscopy and single-port laparoscopy.

24 Feb 2011

Solos Endoscopy to launch new urology product line

Solos Endoscopy, Inc. is pleased to announce that the Company is set to introduce a new product line consisting of urology surgical and diagnostic instruments.

24 Feb 2011

ASGE announces 35 new honorees under Endoscopy Unit Recognition Program

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 35 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States. The ASGE Endoscopy Unit Recognition Program honors endoscopy units that follow the ASGE guidelines on privileging, quality assurance, endoscopy reprocessing and CDC infection control guidelines. To date, 307 endoscopy units have been recognized by ASGE.

23 Feb 2011

Smith & Nephew's OXINIUM material receives C1 price reimbursement in Japan for hip replacements

OXINIUM Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery.

19 Feb 2011

NY neurosurgeon performs deep brain surgeries with hand-held CO2 laser

Lee Eric Tessler, MD, a neurosurgeon specializing in the treatment of brain tumors, is among the first in metro New York to use a new advanced, hand-held CO2 (carbon dioxide) laser for surgeries on certain types of tumors that are buried deep within the base of the skull. The laser allows surgeons to remove these difficult-to-reach tumors in less time, with lower risk of complications, less anesthesia and a smaller possibility of damage to surrounding healthy brain and nerve tissue.

19 Feb 2011

Smith & Nephew introduces Short Modular Femoral Hip System for orthopaedic surgery

At this week's annual meeting of the American Academy of Orthopedic Surgeons, Smith & Nephew Orthopaedic Division introduced its Short Modular Femoral Hip System, a modular total hip replacement stem system that exceeds the versatility and neck strength of a standard, full-size primary hip stem, while providing the stability of the traditionally longer, more invasive implant.

19 Feb 2011

EGS publishes three clinical studies on TIF procedure over past four months

EndoGastric Solutions, the leader in the emerging field of Natural Orifice Surgery (NOS), announced that three clinical studies on transoral fundoplication have been published over the past four months.

18 Feb 2011

Cook Medical launches new histology needle for endoscopic ultrasound

A new histology needle for endoscopic ultrasound (EUS) from Cook Medical is now on the market, giving physicians the ability to retrieve tissue samples from hard-to-reach regions within or adjacent to the GI tract with a minimally invasive procedure.

17 Feb 2011

Study: BPS is safe and effective for patients undergoing therapeutic endoscopy

Researchers from Korea report that, compared with conventional sedation, balanced propofol sedation using propofol in combination with midazolam and meperidine, provided higher health care provider satisfaction, better patient cooperation, and similar adverse event profiles in patients undergoing therapeutic endoscopic procedures.

16 Feb 2011

Aesthetic and dental surgical procedures show greater than average growth

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, standouts in surgical procedures in terms of growth over the next five years are going to be dental implant, facial injectable, optical coherence tomography (OCT) catheter, spinal nonfusion implant, and percutaneous heart valve procedures in North America.

15 Feb 2011

Cantel Medical acquires ConFirm's sterilization monitoring business

CANTEL MEDICAL CORP., through its Crosstex International subsidiary, has further expanded its infection prevention and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc. Based in Denver, Colorado, ConFirm is one of the leading providers of biological monitoring services in North America.

14 Feb 2011

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.

9 Feb 2011

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010, as well as net sales and earnings per share (EPS) guidance for the full year and first quarter 2011.

2 Feb 2011

NQF implements quality measures pertaining to ambulatory emergency and urgent care

To improve healthcare quality and give patients and providers more information about the results of care, the National Quality Forum has endorsed 16 ambulatory care measures, with a particular focus on emergency and urgent care.

19 Jan 2011

Magnetic maneuverable capsule safe and well-tolerated in the stomach

A study from researchers in Germany showed that magnetic maneuvering of a modified capsule endoscope in the stomach of healthy volunteers under clinical conditions is safe, well-tolerated, and technically feasible. Maneuverability of the capsule within the stomach was excellent and visualization of the gastric mucosa, the inner lining of the stomach, was satisfactory in the majority of subjects.

19 Jan 2011

Health Canada approves GORE VIABIL Biliary Endoprosthesis device

W. L. Gore & Associates, Inc. today announced it has received approval from Health Canada for the Removable GORE VIABIL Biliary Endoprosthesis.

17 Jan 2011

Texas Attorney General does not oppose Baylor-Select joint venture

Baylor Health Care System ("Baylor") and Select Medical Corporation ("Select") today announced that they have received notification from the Office of the Attorney General of the State of Texas that it has completed its review of the proposed joint venture between affiliates of Baylor and Select and does not oppose the joint venture.

7 Jan 2011

Sucampo, Takeda initiate dosing in third lubiprostone phase 3 trial for opioid-induced bowel dysfunction

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc. today announced the dosing of the first patient in the third phase 3 clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction (OBD) in subjects with chronic, non-cancer pain, excluding those taking methadone. The primary endpoint is an overall responder rate based on the change from baseline in the reported frequency of spontaneous bowel movements (SBMs).

7 Jan 2011